Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 24. Januar 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8770  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 175394  
   
Population-Based analysis of conditional survival patterns and dynamic prognostic modeling in primary urinary tract lymphoma.
Ann Hematol
Ke R, Nan C.
PMID: 41577855 [PubMed - indexed for MEDLINE]


Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective Study.
Eur Urol Oncol
Mezepo G, Khene ZE, Boustani J, Kleinclauss F, Quivrin M, Neftah Y, Mercier J, Bajeot AS, Mardelli C, Pradere B, Seisen T, Hammoud Y, Bouvier E, Jacquey H, Choffel L, Palkowski T, Khalifa J, Benyoucef A, Pasquier D, Brassart C, Marcq G, Khalladi N, Coutte A, Sargos P, Huck C, Rouprêt M, Roumiguie M, French Committee of Urologic Oncology (CCAFU).
PMID: 41577610 [PubMed - as supplied by publisher]


[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care].
Bull Cancer
Neuzillet Y, Thibault C, Mourey L, Joly C, Balardy L, Faix A, Raynard B, Chaouachi H, Bousquet M, Rioufol C, Alexandre J, Fiard G, Joly F.
PMID: 41577490 [PubMed - as supplied by publisher]


Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer.
BJU Int
Kniep C, Maurer T, Hartwieg BF, Mandel P, Wenzel M, Falkenbach F, Krpina K, Budäus L, Haese A, Salomon G, Steuber T, Graefen M, Tilki D, Preisser F.
PMID: 41577442 [PubMed - as supplied by publisher]


Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data.
JCO Precis Oncol
Rizzo M, Pezzicoli G, Porta C, Povero M, Pradelli L, Sicari E, Barbiero VS, Porta C.
PMID: 41576306 [PubMed - indexed for MEDLINE]


Focal Cryotherapy in Prostate Cancer. Does Gleason Impact Results?
Int Braz J Urol
Mate K, de Pablos-Rodríguez P, Herraiz MB, Román MH, Gómez PP, Fons AC, García MIM, Aliaga JP, Cortés MB, Lozano ÁG, Escrig S JLD, Castañé CG, Part VR, Borja JLCR.
PMID: 41576188 [PubMed - indexed for MEDLINE]


Robot-assisted Partial Nephrectomy with and without Mixed Reality - REALITATEM study.
Int Braz J Urol
Duarte DM Junior, Brum PW, Berger M, Kowalski A, Silva B Neto, Berger AK.
PMID: 41576183 [PubMed - indexed for MEDLINE]


Comment on "The role of apparent diffusion coefficient values in diagnosing prostate cancer for patients with equivocal PI-RADS 3 lesions: a multicenter retrospective study".
Int J Surg
Wang A.
PMID: 41576064 [PubMed - as supplied by publisher]


Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis.
Target Oncol
Fukushima H, Yajima S, Chen W, Hirakawa A, Tanabe K, Fujiwara M, Arita Y, Tanaka H, Masuda H, Fujii Y, Yoshida S.
PMID: 41575641 [PubMed - as supplied by publisher]


Decision tree models combining Bi-parametric vesical imaging reporting and data system and apparent diffusion coefficient metrics for predicting muscle-invasive bladder cancer.
Abdom Radiol (NY)
Sugawara D, Hatakeyama K, Konno M, Tozawa T, Sato T, Murata T, Murasawa E, Narita S, Nanjo H, Habuchi T, Mori N.
PMID: 41575494 [PubMed - as supplied by publisher]


TFE-Altered Renal Cell Carcinoma: A Contemporary Review With Practical Insights and Diagnostic Pearls for Surgical Pathologists.
Adv Anat Pathol
Przybycin CG, Nguyen JK, Alaghehbandan R.
PMID: 41574499 [PubMed - as supplied by publisher]


The role of neuroendocrine differentiation in treatment resistance of prostate cancer and intervention strategies.
Front Oncol
Wang B, Zhang Y, Zhang W.
PMID: 41573638 [PubMed]


Assessing digital rectal examination and prostate-specific antigen knowledge: a study of Syrian medical students' knowledge for prostate cancer screening.
BMC Med Educ
Al-Shafie M, Al-Bitar A, Jouby M, Hiba I, Tello MK, Saifo M.
PMID: 41572262 [PubMed - as supplied by publisher]


Accuracy, readability, and understandability of EAU guidelines bot for testicular cancer.
Int Urol Nephrol
Gallo G, Lombardo R, Pagliarulo V, Sequi MB, Coppola LM, Rosato E, Romagnoli M, De Cillis S, Checcucci E, Amparore D, Ragonese M, Foschi N, Santarelli V, Spatafora P, Tema G, Nacchia A, Cicione A, Franco A, Pastore AL, Al Salhi Y, Rocco B, Gacci M, Fiori C, Finazzi Agrò E, Sciarra A, Tubaro A, De Nunzio C, Next-Gen Research Group.
PMID: 41572051 [PubMed - as supplied by publisher]


ReIMAGINE study insights: Can abbreviated bpMRI transform prostate cancer screening?
Eur Radiol
Muglia VF, Verma S.
PMID: 41572046 [PubMed - as supplied by publisher]


Contemporary management of locally advanced prostate cancer: a narrative review and expert perspective.
World J Urol
Kafka M, Heidegger I.
PMID: 41572035 [PubMed - in process]


Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial.
Eur Urol
Kitamura H, Tsukamoto T, Kakehi Y, Mizusawa J, Shibata T, Sasaki K, Tanikawa T, Hashine K, Fujimoto K, Masumori N, Kobayashi T, Habuchi T, Kimura T, Sugimoto M, Takahashi A, Adachi H, Matsui Y, Hatakeyama S, Ito A, Eto M, Nishiyama H, Urologic Oncology Study Group of the Japan Clinical Oncology Group.
PMID: 41571573 [PubMed - as supplied by publisher]


Efficacy and Safety of Immune Checkpoint Blockade in Locally Advanced or Metastatic Penile Cancer: A Systematic Review and Meta-Analysis.
Clin Genitourin Cancer
Noronha MM, de Almeida LFC, Passos PRC, da Silva LFL, Cappellaro AP, Filho VOC, Santana LG, Park CL, Saldanha EF.
PMID: 41571538 [PubMed - as supplied by publisher]


Natural product-mediated autophagy targeting for prostate cancer: A novel potential therapeutic strategy.
Phytomedicine
Zhang M, Zhong J, Yu M, Wang J, Zhang T, Liu M, Zhang P.
PMID: 41571467 [PubMed - as supplied by publisher]


[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications].
Aktuelle Urol
von Amsberg G, Hartmann A, Eckstein M, Heidegger I.
PMID: 41571001 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 175394    Seite 1 von 8770  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1